By linking pharmacy claims, electronic medical records, social determinants and lab results, we can uncover patterns in adherence, dosing and comorbidities that clinical trials cant reveal
While adipose tissue reduction is therapeutically desirable, disproportionate loss of lean mass may lower resting energy expenditure, impair functional capacity, and potentially compromise long-term metabolic durability
For these reasons, a growing number of clinicians view GLP-1 medications as an essential ingredient in a well-rounded metabolic health optimization program, regardless of whether or not the patients in the program technically meet criteria for diabetes or obesity the conditions for which the FDA originally approved them
Increased anxiety or "jitteriness." Difficulty sleeping
Semaglutide, Tirzepatide, and GLP-1 Options Several medications are now discussed under the GLP-1 weight loss category, but they are not all identical
When paired with the right nutrition plan, it can support steady progress over time